Adamus
Agnieszka Zofia Adamus, West Palm Beach, FL US
Patent application number | Description | Published |
---|---|---|
20100167619 | Combination of articles of apparel or bags and magnetic toys - Provided are novelty clothes and bags with neodymium magnets affixed to their material for attaching magnetic toys. Also, provided is a method of decorating clothes or bags, which method is attaching the magnets under patches sewn, or affixed in other way to the material of clothes or bags, and magnetically attaching the magnetic toys to that patches. | 07-01-2010 |
Grazyna Adamus, Tigard, OR US
Patent application number | Description | Published |
---|---|---|
20110008382 | Compositions and methods using recombinant MHC molecules for the treatment of uveitis - Two-domain MHC polypeptides are useful for modulating activities of antigen-specific T-cells, including for modulating pathogenic potential and effects of antigen-specific T-cells. Exemplary MHC class II-based recombinant T-cell ligands (RTLs) of the invention include covalently linked β1 and α1 domains, and MHC class I-based molecules that comprise covalently linked α1 and α2 domains. These polypeptides may also include covalently linked antigenic determinants, toxic moieties, and/or detectable labels. The disclosed polypeptides can be used to target antigen-specific T-cells, and are useful, among other things, to detect and purify antigen-specific T-cells, to induce or activate T-cells, to modulate T-cell activity, including by regulatory switching of T-cell cytokine and adhesion molecule expression, to treat conditions mediated by antigen-specific T-cells, for example autoimmune diseases or conditions such as acute and recurrent uveitis. | 01-13-2011 |
20120276127 | TREATMENT OF RETINAL DISORDERS WITH RECOMBINANT T CELL RECEPTOR LIGAND (RTL) - Methods are provided for the treatment of a retinal disorder or optic neuritis in a subject. In some embodiments, the methods include administering a therapeutically effective amount of an MHC molecule including covalently linked first, second, and third domains; wherein the first domain is an MHC class II β1 domain and the second domain is an MHC class II α1 domain, wherein the amino terminus of the α1 domain is covalently linked to the carboxy terminus of the β1 domain; or wherein the first domain is an MHC class I α1 domain and the second domain is an MHC class I α2 domain, wherein the amino terminus of the α2 domain is covalently linked to the carboxy terminus of the α1 domain; and wherein the third domain is covalently linked to the first domain and comprises a retinal antigen or an antigen of the central or peripheral nervous system. | 11-01-2012 |
Grazyna Adamus, Gliwice PL
Patent application number | Description | Published |
---|---|---|
20110275729 | PROCESS FOR CONTROLLED DEGRADATION OF POLYHYDROXYALKANOATES AND PRODUCTS OBTAINABLE THEREFROM - The present invention relates to a process for producing polyhydroxyalkanoate oligomers and/or polymers of reduced molecular weight, which comprises reacting at least one polyhydroxyalkanoate (PHA) with at least one carbonate salt at a temperature of from 50° C. to 300° C., preferably from 120° C. to 200° C. The above reaction allows a controlled degradation of the PHA chains which yields oligomers and/or polymers having a controlled molecular weight, which can be modulated in view of the specific application for which the oligomers and/or polymers are intended. Moreover, during the reaction carbon dioxide evolves which produces a foamed material which can be easily processed on an industrial scale. Additionally, the above oligomers and/or polymers, having an end-group bearing a double bond C═C, particularly a crotonate end-group for PHB, can be subjected to subsequent modifications to obtain a wide variety of functional end-groups, for instance carboxyl, carboxylate, hydroxyl, dihydroxyl, oxirane ring, halogen atom. Moreover, the low molecular weight PHAs may be used in the area of controlled delivery systems in agro-chemistry, in the cosmetic industry, in medicine in the form of nano- or microspheres, in household products and in coating systems. | 11-10-2011 |
Jan Adamus, Lodz PL
Patent application number | Description | Published |
---|---|---|
20080221172 | Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection - The invention relates to a method for the treatment or prevention of diseases or conditions associated with vascular endothelium dysfunction or liver injury comprising the administration to a patient in a need of such treatment or prevention of a therapeutically or prophylactically effective amount of a compound selected from the group consisting of: | 09-11-2008 |
20110082177 | N'-NITROXYALKYLNICOTINAMIDES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES - The invention relates to the novel N′-nitroxyalkylnicotinamide derivatives represented by the general formula I wherein R | 04-07-2011 |
20110118316 | Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection - The invention relates to a method for the treatment or prevention of diseases or conditions associated with vascular endothelium dysfunction or liver injury comprising the administration to a patient in a need of such treatment or prevention of a therapeutically or prophylactically effective amount of a compound selected from the group consisting of: | 05-19-2011 |
Ralf Adamus, Nurnberg DE
Patent application number | Description | Published |
---|---|---|
20090198124 | WORKFLOW TO ENHANCE A TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT PROCEDURE - A method and appertaining system are provided for performing an image-assisted subject procedure. The method comprises obtaining at least a first and a second 2D projected image of a 3D subject from a first angle and a second angle. A user selects at least a first point and a second point in each of the first and second 2D images, and the system calculates 3D positions of the first point and the second point based on the selected points in the 3D images and the first and second angles. The, a 3D line is calculated between the first and second points. A further projected 2D image is created that includes the calculated 3D position of at least one of: a) one of the points; and b) the line. The subject procedure is then subsequently performed utilizing the further projected 2D image as a guide. | 08-06-2009 |